S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
S&P 500   2,584.59 (-1.60%)
DOW   21,917.16 (-1.84%)
QQQ   190.40 (-0.85%)
AAPL   254.29 (-0.20%)
FB   166.80 (+0.51%)
MSFT   157.71 (-1.57%)
GOOGL   1,161.95 (+1.36%)
AMZN   1,949.72 (-0.72%)
CGC   14.42 (-0.28%)
NVDA   263.60 (-0.75%)
BABA   194.48 (+1.68%)
MU   42.06 (-5.53%)
GE   7.94 (+0.63%)
TSLA   524.00 (+4.36%)
AMD   45.48 (-4.97%)
T   29.15 (-3.57%)
ACB   0.91 (+2.26%)
F   4.83 (-3.98%)
NFLX   375.50 (+1.22%)
BAC   21.23 (-3.68%)
GILD   74.76 (-1.54%)
PRI   88.48 (-2.46%)
DIS   96.60 (-3.21%)
Log in

Evoke Pharma SEC Filings & 10K Form (NASDAQ:EVOK)

$1.16
+0.04 (+3.57 %)
(As of 03/31/2020 04:00 PM ET)
Today's Range
$1.12
Now: $1.16
$1.21
50-Day Range
$0.82
MA: $1.24
$1.52
52-Week Range
$0.50
Now: $1.16
$2.00
Volume68,500 shs
Average Volume189,418 shs
Market Capitalization$28.11 million
P/E RatioN/A
Dividend YieldN/A
Beta2.04

SEC Filings

Evoke Pharma (NASDAQ:EVOK) SEC Filings

DateFilerForm TypeView
03/12/2020
7:33 AM
Evoke Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/12/2020
7:32 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2020
8:14 PM
CARLSON MARILYN R. (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
7:28 PM
D'Onofrio Matthew J (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2020
7:25 PM
Evoke Pharma (Issuer)
Gonyer David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/11/2020
11:05 AM
Evoke Pharma (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Form SC 13G
01/27/2020
7:35 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2020
3:15 PM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/21/2020
7:36 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2019
8:00 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2019
7:35 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2019
7:35 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2019
7:41 AM
Evoke Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2019
7:35 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2019
7:30 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/08/2019
7:11 AM
Evoke Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/08/2019
7:07 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2019
7:32 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2019
3:37 PM
Evoke Pharma (Issuer)
Gonyer David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:36 PM
D'Onofrio Matthew J (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:33 PM
CARLSON MARILYN R. (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2019
3:30 PM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2019
4:25 PM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
3:10 PM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
5:17 PM
Evoke Pharma (Issuer)
WIDDER KENNETH J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2019
5:14 PM
Evoke Pharma (Issuer)
RHOADS ANN D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2019
5:03 PM
Evoke Pharma (Issuer)
Hill Malcolm R (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2019
4:47 PM
Evoke Pharma (Issuer)
GARNER CAM L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2019
4:44 PM
Brady Todd C (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/03/2019
4:00 PM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2019
5:05 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2019
7:31 AM
Evoke Pharma (Filer)
Form DEFA14A
03/21/2019
7:30 AM
Evoke Pharma (Filer)
Form DEF 14A
03/14/2019
7:31 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2019
7:41 AM
Evoke Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/06/2019
7:35 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2019
7:40 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/08/2019
3:08 PM
CARLSON MARILYN R. (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/08/2019
3:03 PM
Evoke Pharma (Issuer)
Gonyer David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/17/2019
3:58 PM
Evoke Pharma (Subject)
LVP LIFE SCIENCE VENTURES III L.P. (Filed by)
Form SC 13G/A
01/07/2019
7:35 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
9:17 AM
Evoke Pharma (Issuer)
Gonyer David A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
9:16 AM
D'Onofrio Matthew J (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2018
9:15 AM
CARLSON MARILYN R. (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2018
3:24 PM
Evoke Pharma (Issuer)
LATTERELL PATRICK F (Reporting)
LVP GP III, LLC (Reporting)
LVP III Associates, L.P. (Reporting)
LVP III Partners LP (Reporting)
LVP LIFE SCIENCE VENTURES III L.P. (Reporting)
LVPMC, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2018
7:40 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2018
3:05 PM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2018
10:47 AM
Evoke Pharma (Filer)
Form CT ORDER
06/04/2018
6:32 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2018
6:39 AM
Evoke Pharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/14/2018
6:36 AM
Evoke Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2018
6:32 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/10/2018
6:35 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2018
10:34 AM
Evoke Pharma (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
Form SC 13G
04/30/2018
6:35 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/27/2018
3:12 PM
D'Onofrio Matthew J (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
3:09 PM
CARLSON MARILYN R. (Reporting)
Evoke Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/27/2018
7:30 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/18/2018
3:32 PM
Evoke Pharma (Filer)
Form CT ORDER
04/06/2018
3:31 PM
Evoke Pharma (Filer)
Form 8-K/A
04/04/2018
3:47 PM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/26/2018
6:35 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2018
6:30 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2018
8:31 AM
Evoke Pharma (Filer)
Form DEFA14A
03/16/2018
8:31 AM
Evoke Pharma (Filer)
Form DEF 14A
03/07/2018
3:16 PM
Evoke Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/07/2018
3:15 PM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2018
6:35 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2018
6:40 AM
Evoke Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/28/2017
11:15 PM
Evoke Pharma (Filer)
Form EFFECT
12/12/2017
4:30 PM
Evoke Pharma (Filer)
Form S-3/A
This page was last updated on 3/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel